Literature DB >> 33145797

Endoclip papillaplasty restores sphincter of Oddi function: Pilot study.

Xiue Yan1, Wei Zheng1, Yaopeng Zhang1, Hong Chang1, Kun Wang1, Xin Li2, Hejun Zhang1, Yingchun Wang1, Wei Yao1, Ke Li1, Yonghui Huang1.   

Abstract

OBJECTIVES: Endoscopic sphincterotomy (EST) damaged the sphincter of Oddi (SO) function. This study aimed to explore the feasibility and efficacy of endoclip papillaplasty in restoring SO function.
METHODS: This prospective pilot study included consecutive patients with choledocholithiasis (stone size ≥10 mm) who underwent large-EST for stone removal, followed by endoclip papillaplasty, between May 2018 and March 2019.
RESULTS: Thirty patients were enrolled in this trail. Overall, 80% of the patients had a SO basal pressure of >10 mmHg after endoclip papillaplasty. Manometric parameters, including SO basal pressure, phasic wave contraction amplitude, phasic waves per minute, recovered after endoclip papillaplasty (P > 0.05). There were no significant differences in the manometric parameters of SO between healing grades A and B. Six patients developed mild post-endoscopic retrograde cholangiopancreatography pancreatitis, including three that had pancreatic stenting. Bile duct stone recurrence developed in 3.3% of the patients (1/30) during an 18-month follow-up.
CONCLUSIONS: Endoclip papillaplasty might restore SO function and possibly prevented biliary stone and cholangitis recurrence.
© 2020 Japan Gastroenterological Endoscopy Society.

Entities:  

Keywords:  choledocholithiasis; endoclip papillaplasty; sphincter of Oddi; sphincterotomy

Year:  2020        PMID: 33145797     DOI: 10.1111/den.13887

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   7.559


  1 in total

1.  Comparison between endoscopic submucosal resection and surgery for the curative resection of undifferentiated-type early gastric cancer within expanded indications: a nationwide multi-center study.

Authors:  Ji Yong Ahn; Young-Ii Kim; Woon Geon Shin; Hyo-Joon Yang; Su Youn Nam; Byung-Hoon Min; Jae-Young Jang; Joo Hyun Lim; Jie -Hyun Kim; Wan Sik Lee; Bong Eun Lee; Moon Kyung Joo; Jae Myung Park; Hang Lak Lee; Tae- Geun Gweon; Moo In Park; Jeongmin Choi; Chung Hyun Tae; Young-Woo Kim; Boram Park; I I Ju Choi
Journal:  Gastric Cancer       Date:  2020-11-19       Impact factor: 7.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.